Research & Development
Galvanize Therapeutics has conducted years of intensive
research to elucidate the impact of its electrosurgical devices on
core biological processes, and this research is ongoing today.
research to elucidate the impact of its electrosurgical devices on
core biological processes, and this research is ongoing today.
In our quest to provide high-quality and useful data on patient outcomes over time and across populations, we believe that Galvanize transcends customary “medtech” practices. Our data-driven approach enables us to truly partner with physician teams and offer insights across the care spectrum, including in areas that are synergistic with or potentially competitive with drugs.
Research and Clinical Development
Clinical Trials
Recruiting
Active, Not Recruiting
Completed
Publications
Abstracts
Bronchial Rheoplasty Treatment for Chronic Bronchitis Using the RheOx System: 12-Month Results of a Prospective, Multi-Center Study
Late Breaking Abstract – Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study
First-in-Human Results of Bronchial Rheoplasty: An Endobronchial Treatment for Chronic Bronchitis (CB)
Bronchial Rheoplasty Increases Distal Airway Volume in Chronic Bronchitis
Histopathologic Results Post Bronchial Rheoplasty Late Breaking Abstract – First-in-Human Results of Bronchial Rheoplasty: An Endobronchial Treatment for Chronic Bronchitis (CB)
Late Breaking Abstract – Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study
First-in-Human Results of Bronchial Rheoplasty: An Endobronchial Treatment for Chronic Bronchitis (CB)
Bronchial Rheoplasty Increases Distal Airway Volume in Chronic Bronchitis
Histopathologic Results Post Bronchial Rheoplasty Late Breaking Abstract – First-in-Human Results of Bronchial Rheoplasty: An Endobronchial Treatment for Chronic Bronchitis (CB)
